• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Biotech

    Vyne`s BET Inhibitor Fails Phase 2 Vitiligo Trial, Sinking Stock

    FIERCE BIOTECH

    Vyne’s psoriasis drug hit with FDA hold over testicular toxicity

    FIERCE BIOTECH

    VYNE Therapeutics Reports Positive Phase 1a SAD Data For VYN202

    GLOBENEWSWIRE

    VYNE Gets FDA IND Clearance For BET Inhibitor VYN202

    GLOBENEWSWIRE

    VYNE Announces Positive Biomarker Data from Successful Phase 1b Trial of VYN201

    GLOBENEWSWIRE

    VYNE Therapeutics Reports Positive Results from Preclinical Models for VYN202

    GLOBENEWSWIRE

    Vyne aims to raise $88M; Sanofi invests in gene therapy company

    ENDPTS

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.